Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Flunarizine 5mg capsules
0406000E0AAAAAA
|
Flunarizine dihydrochloride | Flunarizine dihydrochloride | Central Nervous System | 267 |
|
Flunarizine 10mg tablets
0406000E0AAABAB
|
Flunarizine dihydrochloride | Flunarizine dihydrochloride | Central Nervous System | 190 |
|
Flunarizine 5mg tablets
0406000E0AAADAD
|
Flunarizine dihydrochloride | Flunarizine dihydrochloride | Central Nervous System | 5 |
|
Sibelium 5mg tablets
0406000E0BBACAD
|
Sibelium | Flunarizine dihydrochloride | Central Nervous System | 1 |
|
Flunarizine 20mg tablets
0406000E0AAAEAE
|
Flunarizine dihydrochloride | Flunarizine dihydrochloride | Central Nervous System | No data available |
|
Flurizin 10 tablets
0406000E0BCAAAB
|
Flurizin | Flunarizine dihydrochloride | Central Nervous System | No data available |
|
Flurizin 5 tablets
0406000E0BCABAD
|
Flurizin | Flunarizine dihydrochloride | Central Nervous System | No data available |
|
Migarid-10 tablets
0406000E0BDAAAB
|
Migarid-10 | Flunarizine dihydrochloride | Central Nervous System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.